Vital Signs - Next-generation Sequencing Bioinformatics: Challenges and Opportunities

Vital Signs - Next-generation Sequencing Bioinformatics: Challenges and Opportunities

 

RELEASE DATE
08-Feb-2010
REGION
North America
Deliverable Type
Market Research
Research Code: 9561-00-A0-00-00
SKU: HC00589-NA-MR_04062
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00589-NA-MR_04062

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on February 8, 2010, provides a strategic overview of challenges and opportunities in next-generation sequencing bioinformatics. Additionally, a company spotlight is provided for CLC bio, a company focused on bioinformatics needs in genomics research, drug discovery, diagnostics, and next-generation sequencing. Reimbursement and regulatory news from the FDA is also provided for the week of January 20, 2010.

Table of Contents

This week's issue:

This issue of Vital Signs, released on February 8, 2010, provides a strategic overview of challenges and opportunities in next-generation sequencing bioinformatics. Additionally, a company spotlight is provided for CLC bio, a company focused on bioinformatics needs in genomics research, drug discovery, diagnostics, and next-generation sequencing. Reimbursement and regulatory news from the FDA is also provided for the week of January 20, 2010.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-A0-00-00
Is Prebook No